• Shuo-Yang Shi, Qing Zhou, Zong-Qi He, Zhao-Feng Shen, Wei-Xin Zhang, Dan Zhang, Cheng-Biao Xu, Ji Geng, Ben-Sheng Wu, and Yu-Gen Chen.
• Nanjing University of Chinese Medicine, Changzhou Hospital of Traditional Chinese Medicine, Changzhou.
• Medicine (Baltimore). 2020 Apr 1; 99 (16): e19720e19720.

BackgroundHemorrhoidal disease (HD) is one of the commonest proctologic condition in the general population. Medical therapy for HD has not been formally confirmed due to the inconsistent of results. Liang-Xue-Di-Huang Decoction, a kind of ancient Chinese classical prescription, has been used to treat HD from the 19th century in China. However, clinical research of Liang-Xue-Di-Huang Decoction in the treatment of HD was lack. We designed this study to evaluate the efficacy and safety of Liang-Xue-Di-Huang Decoction in the treatment of HD.Methods/DesignA randomized, controlled, double blind, double-mimetic agent, and multicenter trial to evaluate the efficacy and safety of Liang-Xue-Di-Huang Decoction is proposed. HD patients (stage I, II, III) will be randomly assigned into experimental group or control group. HD patients will receive a 7-day treatments and a 7-day follow-up. The primary outcome measure is the Hemorrhoid Bleeding Score in 7 and 14 days. The Secondary outcome measures are Goligher prolapse score and quality-of-life score in 7 and 14 days.DiscussionThis study will provide objective evidences to evaluate the efficacy and safety of Liang-Xue-Di-Huang Decoction in treatment of HD.

15 keywords...

hide…